Abstract
The alpha 2-adrenoceptor agonist, clonidine (0.001-1 mg/kg, IP), dose-dependently induced mydriasis in conscious rats (ED50 0.088 mg/kg). This response was maximal when measured 10 min after clonidine injection and was of about 30-min duration. The noradrenaline releasing agent, methamphetamine (0.75 mg/kg, IP), also increased pupil diameter. Clonidine (0.03 mg/kg, IP)-induced mydriasis was inhibited in a dose-related fashion by the alpha 2-adrenoceptor antagonists, idazoxan (0.03-3 mg/kg, IP) and yohimbine (0.03-3 mg/kg, IP), but was unaltered by the alpha 1- or beta-adrenergic antagonists, prazosin (1 and 3 mg/kg, IP) or pindolol (1 and 3 mg/kg, IP). Methamphetamine (0.75 mg/kg, IP)-induced mydriasis was similarly inhibited by idazoxan (1 mg/kg, IP) and yohimbine (1 mg/kg, IP). These data argued strongly that central alpha 2-adrenoceptors are involved in the mediation of mydriasis. The synaptic location of these receptors was determined using DSP-4 (50 mg/kg x 2, IP) to lesion noradrenergic neurones: this produced a 64% depletion of noradrenaline in the midbrain (containing the Edinger-Westphal nucleus responsible for mydriasis) and reduced the mydriatic effect of methamphetamine (0.75 mg/kg, IP) to a similar extent (72%), wh...Continue Reading
References
Aug 1, 1979·European Journal of Pharmacology·T Gherezghiher, M C Koss
Jul 18, 1977·Psychopharmacology·L G SharpeW R Martin
May 28, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·M C Koss, H D Christensen
Nov 1, 1975·European Journal of Pharmacology·M RaiteriG Levi
Jan 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·A MenarguesJ A García-Sevilla
Jan 1, 1990·Journal of Ocular Pharmacology·H D ChristensenM C Koss
Jan 31, 1989·European Journal of Pharmacology·D K Pitts, J Marwah
Oct 24, 1989·European Journal of Pharmacology·D J HealW R Buckett
Feb 1, 1986·Journal of Pharmacological Methods·M C Koss
Jan 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·J A HeyM C Koss
Mar 1, 1983·British Journal of Pharmacology·T L BerridgeI F Tulloch
Nov 1, 1984·Neuropharmacology·D J Heal
Aug 17, 1984·European Journal of Pharmacology·H Hallman, G Jonsson
Nov 2, 1993·European Journal of Pharmacology·D J HealW R Buckett
Citations
Oct 15, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Tiina LeinoRaimo Virtanen
Apr 24, 1995·European Journal of Pharmacology·D J HealW R Buckett
Apr 16, 1999·European Journal of Pharmacology·V KackerY K Gupta
Mar 2, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jean-Philippe RénéricLuis Stinus
Oct 12, 1999·British Journal of Pharmacology·E S RobinsonA L Hudson
Apr 26, 2000·British Journal of Pharmacology·E S RobinsonA L Hudson
Aug 29, 2000·Journal of Autonomic Pharmacology·A L HudsonD J Nutt
Aug 15, 2014·Journal of Psychopharmacology·C Richard ChapmanYoshio Nakamura
May 12, 2017·Dose-response : a Publication of International Hormesis Society·Joanna Raczak-GutknechtRoman Kaliszan
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Ryan K BachtellAndrey E Ryabinin
Jan 21, 2018·Applied Microbiology and Biotechnology·Narendra KumarSudhir Kumar Tomar
Jun 8, 2013·Pharmacological Reports : PR·Joanna Raczak-GutknechtRoman Kaliszan
Jan 15, 2011·The Journal of Pharmacology and Experimental Therapeutics·Michel R CorbozJohn A Hey
Apr 1, 2021·British Journal of Pharmacology·James R Docherty, Hadeel A Alsufyani